Provider review
Gala Health review
A named microdose tirzepatide tier, nationwide, with a brand-name escape hatch.
It prices a low tirzepatide tier separately instead of charging the standard rate for a smaller dose.
Price as published
Compounded tirzepatide microdose $149/mo · standard compounded tirzepatide $179/mo · 3-month plans from $199 · brand Ozempic ~$1,299
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The verdict
Gala Health prices a compounded microdose tirzepatide tier below its standard compounded tier, which is the behaviour this site is looking for — a lower dose that actually costs less rather than the same. It prescribes in all 50 states, one of the widest footprints here, and it keeps a brand-name pathway open if you decide to switch tracks. The caveats are structural: it is injectable only, so a small dose means drawing a partial unit, and it is a newer operator with a correspondingly short public record.
The trade-off we would want you to read first
The brand-name pathway (~$1,299) is far pricier than the compounded microdose tier
Who it suits, and who it does not
A good fit if
- Tirzepatide is the molecule you want and you intend to stay at a low dose
- You want the option of moving to a brand-name product later without changing provider
- You are in a state that narrows your options — it prescribes in all 50
Look elsewhere if
- You want a needle-free route: there is no oral or sublingual option
- You want a long, verifiable operating history rather than a newer clinical team
- You are pricing against the brand-name pathway, which is a different order of cost entirely
How the programme works
An online intake is reviewed by Gala's clinical team (operated by AI Coaching Inc), then compounded tirzepatide — including a low microdose tier at $149/mo — is shipped to you, with 3-month plans starting around $199. Gala is unusual among low-dose telehealth in offering a brand-name pathway (e.g., Ozempic at roughly $1,299) alongside the compounded arm, and it prescribes across all 50 states. It also sits next to a broader hormone/menopause (HRT) practice, so it can appeal to patients layering metabolic and midlife-hormone care.
At a glance
- Pricing structure
- Varies by dose, plan or tier
- Consult
- Included in the price
- Compounding
- Network
- Labs
- Optional
- Dietitian support
- Not included
Strengths
- Low compounded microdose tirzepatide entry at $149/mo, well suited to a start-low approach
- Prescribes in all 50 states — one of the widest footprints in this list
- Offers a brand-name GLP-1 pathway in addition to compounded, so patients can switch tracks
- Adjacent HRT/menopause care for patients combining metabolic and hormone treatment
The other trade-offs
- Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven
- No oral/sublingual option yet — injectable only
- A newer operator, so it has a shorter public track record than established telehealth platforms
Before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomised trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
Where this sits on the board
Gala Health is one of 24 low-dose GLP-1 providers we track. The board lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Funding & disclosures
- A number of links are affiliate or referral links.
- Begin treatment through one and we may earn a commission via the Katalys network — at no added cost to you.
- What we write about a provider is the same either way — unflattering findings about one that pays us stay in.
- Full detail: disclosure page.